Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flavio Vincenti

Showing results (11-20 of 132) with videos related to

Pageof 14
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 27, 2007
Costimulation blockade--what will the future bring?Flavio Vincenti
Kidney International|May 25, 2012
Are calcineurin inhibitors-free regimens ready for prime time?Flavio Vincenti
Transplant International : Official Journal of the European Society for Organ Transplantation|September 15, 2004
Interleukin-2 receptor antagonists and aggressive steroid minimization strategies for kidney transplant patientsFlavio Vincenti
Current Opinion in Nephrology and Hypertension|August 13, 2016
Current status of costimulatory blockade in renal transplantationDavid Wojciechowski, Flavio Vincenti
Nature Reviews. Nephrology|June 27, 2009
Transplantation: To convert or not to convert: lessons from the CONVERT trialSuphamai Bunnapradist, Flavio Vincenti
Advances in Chronic Kidney Disease|October 16, 2016
Costimulatory Blockade and Use of mTOR Inhibitors: Avoiding Injury Part 2David Wojciechowski, Flavio Vincenti
Current Opinion in Organ Transplantation|October 6, 2011
Targeting JAK3 in kidney transplantation: current status and future optionsDavid Wojciechowski, Flavio Vincenti
Seminars in Immunology|August 23, 2011
Challenges and opportunities in targeting the costimulation pathway in solid organ transplantationDavid Wojciechowski, Flavio Vincenti
Current Opinion in Organ Transplantation|October 9, 2010
How the development of new biological agents may help minimize immunosuppression in kidney transplantation: the impact of belataceptDavid Wojciechowski, Flavio Vincenti
Expert Opinion on Investigational Drugs|July 12, 2013
Tofacitinib in kidney transplantationDavid Wojciechowski, Flavio Vincenti
Pageof 14

Showing results (11-20 of 132) with videos related to

Sort By:
Pageof 14
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 27, 2007
Costimulation blockade--what will the future bring?Flavio Vincenti
Kidney International|May 25, 2012
Are calcineurin inhibitors-free regimens ready for prime time?Flavio Vincenti
Transplant International : Official Journal of the European Society for Organ Transplantation|September 15, 2004
Interleukin-2 receptor antagonists and aggressive steroid minimization strategies for kidney transplant patientsFlavio Vincenti
Current Opinion in Nephrology and Hypertension|August 13, 2016
Current status of costimulatory blockade in renal transplantationDavid Wojciechowski, Flavio Vincenti
Nature Reviews. Nephrology|June 27, 2009
Transplantation: To convert or not to convert: lessons from the CONVERT trialSuphamai Bunnapradist, Flavio Vincenti
Advances in Chronic Kidney Disease|October 16, 2016
Costimulatory Blockade and Use of mTOR Inhibitors: Avoiding Injury Part 2David Wojciechowski, Flavio Vincenti
Current Opinion in Organ Transplantation|October 6, 2011
Targeting JAK3 in kidney transplantation: current status and future optionsDavid Wojciechowski, Flavio Vincenti
Seminars in Immunology|August 23, 2011
Challenges and opportunities in targeting the costimulation pathway in solid organ transplantationDavid Wojciechowski, Flavio Vincenti
Current Opinion in Organ Transplantation|October 9, 2010
How the development of new biological agents may help minimize immunosuppression in kidney transplantation: the impact of belataceptDavid Wojciechowski, Flavio Vincenti
Expert Opinion on Investigational Drugs|July 12, 2013
Tofacitinib in kidney transplantationDavid Wojciechowski, Flavio Vincenti
Pageof 14